Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

1. Jennette JC. Rapidly progressive and crescentic glomerulonephritis. Kidney Int 63:1164-1172, 2003.

2. Jennette JC, Falk RJ. Small vessel vasculitis. N Engl J Med 337:1512-1523, 1997.

3. Jennette JC, Falk RJ. The pathology of vasculitis involving the kidney. Am J Kidney Dis 24:130-141, 1994.

4. Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J Clin Res Ed 292:301-304, 1986.

5. Bajema IM, Hagen EC, Ferrario F, et al. Renal granulomas in systemic vasculitis. EC/BCR Project for ANCA-Assay Standardization. Clin Nephrol 48:16-21, 1997.

6. Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45:397-406, 2005.

7. Hellmark T, Johansson C, Wieslander J. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome. Kidney Int 46:823-829, 1994.

8. Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulone-phritis. Am J Kidney Dis 26:439-445, 1995.

9. Niles JL, Bottinger EP, Saurina GR, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 56:440-445, 1996.

10. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033-1042, 2001.

11. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculiti-des. Proposal of an international consensus conference. Arthritis Rheum 37:187-192, 1994.

12. Harris AA, Falk RJ, Jennette JC. Crescentic glomerulonephritis with a paucity of glomerular immunoglobulin localization. Am J Kidney Dis 32:179-184, 1998.

13. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18:3-13, 2001.

14. Jennette JC, Falk RJ. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol Dial Transplant 13 (suppl) 1:16-20, 1998.

15. Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955-963, 2002.

16. Xiao H, Heeringa P, Liu Z, et al. A major role for neutrophils in anti-myeloperoxidase antibody induced necrotizing and crescentic glomerulone-phritis. Am J Pathol 167:39-45, 2005.

17. Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93:398-401, 2004.

18. Bacon PA. Therapy of vasculitis. J Rheumatol 21:788-790, 1994.

19. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:33-39, 1996.

20. Bajema IM, Hagen EC, Ferrario F, et al. Renal granulomas in systemic vas-culitis. EC/BCR Project for ANCA-Assay Standardization. Clin Nephrol 48:16-21, 1997.

21. Guillevin L, Lhote F. Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 41:2100-2105, 1998.

22. Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 41:785-797, 1991.

23. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347, 1986.

24. Sonnenblick M, Nasher G, Rosin A. Nonclassical organ involvement in temporal arteritis. Semin Arthritis Rheum 19:183-190, 1989.

25. Lagneau P, Michel JB. Renovascular hypertension and Takayasu's disease. J Urol 134:876-879, 1985.

Section V

Vascular Diseases

Was this article helpful?

0 0


Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook

Post a comment